Search - tctmd.com

Displaying 141 - 160 of 304

Sort: Relevancy | Date

Presentation TCT 2018

State-of-the-Art: Medical Therapies for CHF (With a Focus on Diabetes)

Presenter: James E. Udelson, Clyde W. Yancy, Ileana L. Pina

September 22, 2018

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

News Conference News TCT 2018

Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014

Yael L. Maxwell

September 21, 2018

Presentation TCT 2017

RESOLVE/SAVORY: Critique and Unanswered Questions

Presenter: David J. Moliterno, Vinod H. Thourani, Mohamed Abdel-Wahab

November 01, 2017

Presentation TCT 2017

RESOLVE/SAVORY: Topline Findings and Practice Implications

Presenter: David J. Moliterno, Vinod H. Thourani, Lars Sondergaard

November 01, 2017

Presentation TCT 2017

Case #2 Conclusion: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How We Treated

Presenter: David J. Maron, Alan C. Yeung, Vasim Farooq

November 01, 2017

Presentation TCT 2017

Case #3 Introduction: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Vasim Farooq

November 01, 2017

Presentation TCT 2017

Case #2 Introduction: An Asymptomatic Diabetic Patient With Normal Exercise Tolerance and Multivessel Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Frederick Feit

November 01, 2017

Presentation TCT 2017

Case #1 Conclusion: A Diabetic Patient With Left Main Disease How We Treated

Presenter: David J. Maron, Alan C. Yeung, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Case #1 Introduction: A Diabetic Patient With Left Main Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Should Pre-Diabetes Affect Revascularization Decisions?

Presenter: David J. Maron, Alan C. Yeung, Clemens von Birgelen

November 01, 2017

Presentation TCT 2017

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

Presenter: David J. Maron, Alan C. Yeung, Michael E. Farkouh

November 01, 2017

Presentation TCT 2017

When Is Medical Therapy the Best Choice in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung

November 01, 2017

Presentation TCT 2017

Is There a Preferred Stent for the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Upendra Kaul

November 01, 2017

Presentation TCT 2017

When Should PCI Be Preferred in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Sripal Bangalore

November 01, 2017

Presentation TCT 2017

When Should CABG Be Preferred in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Jack Boyd

November 01, 2017

News Conference News TCT 2016

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

L.A. McKeown

November 07, 2016

News Conference News TCT 2016

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

Case Presentation: Diabetes, Comorbidities, and Multivessel Disease

Presenter: John A. Bittl, David J. Maron, Kishore J. Harjai

November 01, 2016

Presentation TCT 2016

Diabetes in the NOBLE Trial

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Olli A. Kajander

October 31, 2016

Advertisement

State-of-the-Art: Medical Therapies for CHF (With a Focus on Diabetes)

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014

RESOLVE/SAVORY: Critique and Unanswered Questions

RESOLVE/SAVORY: Topline Findings and Practice Implications

Case #2 Conclusion: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How We Treated

Case #3 Introduction: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How Should We Treat?

Case #2 Introduction: An Asymptomatic Diabetic Patient With Normal Exercise Tolerance and Multivessel Disease How Should We Treat?

Case #1 Conclusion: A Diabetic Patient With Left Main Disease How We Treated

Case #1 Introduction: A Diabetic Patient With Left Main Disease How Should We Treat?

Should Pre-Diabetes Affect Revascularization Decisions?

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

When Is Medical Therapy the Best Choice in the Diabetic Patient?

Is There a Preferred Stent for the Diabetic Patient?

When Should PCI Be Preferred in the Diabetic Patient?

When Should CABG Be Preferred in the Diabetic Patient?

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Case Presentation: Diabetes, Comorbidities, and Multivessel Disease

Diabetes in the NOBLE Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content